14
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Influence of Epstein-Barr Virus Encoded Latent Membrane Protein 1 on the Expression of CD23 Antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg Cells. A Morphometric Analysis

, &
Pages 95-101 | Received 01 Jun 1992, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Satomi Ueda, Yasuhiro Maeda, Terufumi Yamaguchi, Hitoshi Hanamoto, Yasuki Hijikata, Miyako Tanaka, Shunsuke Takai, Chikara Hirase, Yasuyoshi Morita & Akihisa Kanamaru. (2008) Influence of Epstein–Barr virus infection in adult T-cell leukemia. Hematology 13:3, pages 154-162.
Read now

Articles from other publishers (13)

Muzna Said Rashed Al-Mamari, Shadia Al-Sinawi, Fathiya Salim AL-Rahbi & Mohamed Mabruk. (2022) The Prevalence and the Patterns of the Expression of Latent Epstein-Barr Virus in Hodgkin’s and Non-Hodgkin’s Lymphomas Among Patients in Oman: Immunohistochemistry Versus in Situ Hybridization.. Biomedical and Pharmacology Journal 15:2, pages 819-829.
Crossref
J A Anderton, S Bose, M Vockerodt, K Vrzalikova, W Wei, M Kuo, K Helin, J Christensen, M Rowe, P G Murray & C B Woodman. (2011) The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's Lymphoma. Oncogene 30:17, pages 2037-2043.
Crossref
Mohamed E. SalamaM. Rajan Mariappan, Kedar Inamdar, Sheryl R. Tripp & Sherrie L. Perkins. (2009) The Value of CD23 Expression as an Additional Marker in Distinguishing Mediastinal (Thymic) Large B-Cell Lymphoma From Hodgkin Lymphoma. International Journal of Surgical Pathology 18:2, pages 121-128.
Crossref
J I Cohen. (2005) HMG CoA reductase inhibitors (statins) to treat Epstein–Barr virus-driven lymphoma. British Journal of Cancer 92:9, pages 1593-1598.
Crossref
Sabine Blaschke, Horst Hannig, Christian Buske, Franz‐J. Kaup, Gerhard Hunsmann & Walter Bodemer. (2001) Expression of the simian epstein‐barr virus‐encoded latent membrane protein‐1 in malignant lymphomas of SIV‐infected rhesus macaques. Journal of Medical Virology 65:1, pages 114-120.
Crossref
U Axdorph, A Porwit-MacDonald, J Sjöberg, G Grimfors, M Ekman, W Wang, P Biberfeld & M Björkholm. (1999) Epstein–Barr virus expression in Hodgkin’s disease in relation to patient characteristics, serum factors and blood lymphocyte function. British Journal of Cancer 81:7, pages 1182-1187.
Crossref
Ilse Christiansen, Christer SundstrÖm, Gunilla Enblad & Thomas H. Tötterman. (2008) Soluble vascular cell adhesion molecule‐1 (sVCAM‐1) is an independent prognostic marker in Hodgkin's disease. British Journal of Haematology 102:3, pages 701-709.
Crossref
Alfred S. Evans & Nancy E. Mueller. 1997. Viral Infections of Humans. Viral Infections of Humans 895 933 .
Jennifer L. Craigen & Jane E. Grundy. (1996) CYTOMEGALOVIRUS INDUCED UP-REGULATION OF LFA-3 (CD58) AND ICAM-1(CD54) IS A DIRECT VIRAL EFFECT THAT IS NOT PREVENTED BY GANCICLOVIR OR FOSCARNET TREATMENT1. Transplantation 62:8, pages 1102-1108.
Crossref
Juan Carlos de la Torre & Michael B.A. Oldstone. 1996. 311 343 .
Ruth F. Jarrett. 1996. Etiology of Hodgkin’s Disease. Etiology of Hodgkin’s Disease 53 63 .
Q Tao, G Srivastava, S L Loke & F C Ho. (1994) Lack of correlation between expression of Epstein-Barr virus (EBV) latent membrane protein and bcl-2 oncoprotein in vivo.. Journal of Clinical Pathology 47:7, pages 589-591.
Crossref
ANNE F. LAURITZEN, ULLA HØRDING & HENRIK W. NIELSEN. (1994) Epstein-Barr virus and Hodgkin's disease: A comparative immunological, in situ hybridization, and polymerase chain reaction study . APMIS 102:7-12, pages 495-500.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.